A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis

Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA

(2018) Jens Klotsche et al.   ANNALS OF THE RHEUMATIC DISEASES

Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial

(2018) Petra Hissink Muller et al.   ANNALS OF THE RHEUMATIC DISEASES

Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial

(2017) Angelo Ravelli et al.   LANCET

Predictors of methotrexate response in turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis

(2017) Ezgi Deniz Batu et al.   TURKISH JOURNAL OF PEDIATRICS

Management of juvenile idiopathic arthritis: hitting the target

(2015) Claas Hinze et al.   Nature Reviews Rheumatology

Clinically Inactive Disease in a Cohort of Children with New-onset Polyarticular Juvenile Idiopathic Arthritis Treated with Early Aggressive Therapy: Time to Achievement, Total Duration, and Predictors

(2014) C. A. Wallace et al.   JOURNAL OF RHEUMATOLOGY

Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review

(2014) EH van Dijkhuizen et al.   Pediatric Rheumatology

Predictors of response to methotrexate in juvenile idiopathic arthritis

(2014) Mohamed Albarouni et al.   Pediatric Rheumatology

It Is Worth Including Assessment of Disease Activity State in Juvenile Arthritis Clinical Trials

(2013) Alessandro Consolaro et al.   ARTHRITIS CARE & RESEARCH

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis

(2012) Maja Bulatović et al.   ANNALS OF THE RHEUMATIC DISEASES

Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis

(2011) Carol A. Wallace et al.   ARTHRITIS AND RHEUMATISM

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

(2011) Timothy Beukelman et al.   ARTHRITIS CARE & RESEARCH

Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial

(2010) I. Vilca et al.   ANNALS OF THE RHEUMATIC DISEASES

Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in RemissionA Randomized Clinical Trial

(2010) Dirk Foell   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Achievement of a State of Inactive Disease at Least Once in the First 5 Years Predicts Better Outcome of Patients with Polyarticular Juvenile Idiopathic Arthritis

(2009) A. MAGNANI et al.   JOURNAL OF RHEUMATOLOGY

Assessing current outcomes of juvenile idiopathic arthritis: A cross-sectional study in a tertiary center sample

(2008) Nicoletta Solari et al.   ARTHRITIS AND RHEUMATISM